baber/WOPTO huggingface dataset:
Patent NZ-506299-A (NZ)
Title: Method for exploring and displaying tissues of human or animal origin from a high frequency ultrasound probe where high frequency ultrasound waves are focussed to a penetration distance of between 20mm and 30mm
Inventor: PUECH MICHEL
IPC: A61B3/10
Filed: 1999-01-12
Abstract: Describes a method for exploring and displaying tissues of human or animal origin which consists in: positioning an ultrasound probe (1) carried by a head steered by means of a three-dimensional positioning system (2), in particular computer-controlled, perpendicular to the tissue structure; controlling the probe such that it generates convergent high frequency ultrasound wave beams (of the order of *= 50 MHz), said waves being focused at a predetermined zone of the tissues, over a penetration distance ranging between 20 and 30 mm; scanning the tissue structure by the computer-controlled (3) positioning system (2), by carrying out parallel acquisition, by the computer (3) of signals reflected by the tissue structure; carrying out various signal processing operations on the data derived from scanning, to improve the reproduction of data and facilitate interpretation thereof by the practitioner.
Patent NZ-506516-A (NZ)
Title: Method for treating process water containing metal ions from bleaching of lignocellulosic pulp
Inventor: RAMPOTAS CHRISTOS
IPC: D21C9/10
Filed: 1999-01-18
Abstract: A method for treating process water containing metal ions arising from bleaching lignocellulous pulp.  The method comprises the steps a) adjusting the Mg2+ content of the process water to form a flocculation base for metals and organic substance, b) supplying a carbonate source to the process water to precipitate calcium as calcium carbonate, c) increasing the pH of the process water by adding white liquor to precipitate metals such as metal hydroxides, d) adding a flocculant to the process water, and e) separating the precipitated, flocculated metal compounds from the process water by flotation.
Patent NZ-511887-A (NZ)
Title: Chlamydia antigens and corresponding DNA fragments and uses thereof
Inventor: MURDIN ANDREW DAVID
IPC: A61P31/04
Filed: 1999-10-28
Abstract: A polynucleotide comprising a polynucleotide from a strain of Chlamydia comprising the nucleotide sequence of SEQ ID NO:1. The polynucleotide encodes a polypeptide having the amino acid sequence of SEQ ID NO:2. Also described are pharmaceutical compositions comprising either a vaccine vector comprising the polynucleotide or the polypeptide. The polypeptide or vaccine vector can be used to prepare a medicament to induce an immune response in a mammal. Also described are methods of detecting the presence of Chlamydia in a sample and for producing and purifying the polypeptide.
Patent NZ-514567-A (NZ)
Title: Pyridoxal analogues for vitamin B-6 disorders
Inventor: HAQUE WASIMUL
IPC: A61P7/00
Filed: 2000-03-07
Abstract: Compounds of the formula V or a pharmaceutically acceptable acid addition salt thereof; wherein; R1 is (C1-8)alkyl, or (C2-8) alkenyl, in which alkyl or alkenyl can be interrupted by nitrogen, oxygen, or sulfur, and can be substituted at the terminal carbon by hydroxy, (C1-4)alkoxy, (C1-4)alkanoyloxy, alkanoyloxyaryl, alkoxyalkanoyl, alkoxycarbonyl, or dialkylcarbamoyloxy;  (C1-4)alkoxy; dialkylamino; (C1-4)alkanoyloxy; alkanoyloxyaryl; alkoxyalkanoyl; alkoxycarbonyl; dialkylcarbamoyloxy; or aryl, aryloxy, arylthio, or aralkyl, in which aryl can be substituted by (C1-4)alkyl, (C1-4)alkoxy, amino, hydroxy, halo, nitro, or (C1-4)alkanoyloxy. The compounds are used to treat vitamin B6 deficiency.
Patent NZ-514686-A (NZ)
Title: Additive for preparing lightweight concrete including an organic polymeric material and an air entraining agent
Inventor: NAJI BASIL TAHA
IPC: C04B38/02
Filed: 2000-04-10
Abstract: An additive for use in the preparation of lightweight concrete, which include a blend of 40% to 99% of organic polymeric material 1% to 60% of an air entraining agent.  The additive is particularly suitable for the preparation of lightweight concrete that uses polystyrene aggregate.  It provides for dispersion of the polystyrene aggregate and bond between the polystyrene aggregate and surrounding cementitious binder.  The resultant lightweight concrete formulation may be pumped and is particularly suitable for sandwich wall construction. The organic polymeric material is selected from a group consisting of hydroxymethylcellulose, hydroxyethyl cellulose, hydroxy propyl methyl cellulose, starch, alginate, polyvinyl alcohol, polyethylene oxide and polypropylene oxide. The air entraining agent can be either one or more nonionic, cationic or anionic surfactants and may be a sodium salt of alpha olefin sulphonate, or sodium lauryl sulphate or sulphonate.
Patent NZ-520779-A (NZ)
Title: Apparatus and method for shredding blocks of material
Inventor: OWENS SHAWN
IPC: A23P1/00
Filed: 2001-01-24
Abstract: Disclosed is an apparatus for shredding a block of material having a width, a height and a front face defined by the most downstream cross-section of the height and width of the block, the apparatus comprising a shredding unit having a plurality of blades, the blades revolving about an axis, wherein the blades are mounted between and connected with a pair of plates, a drive unit that rotates the cutting blades around the axis, and a feed unit that moves the block of material on a feed plane toward the shredding unit in a feeding direction, the feed unit disposed upstream of the shredding unit, and the feeding direction being generally perpendicular to the axis about which the blades rotate, the blades cutting shreds of material from the front face of the block.
Patent NZ-522076-A (NZ)
Title: Inhibitors of human phosphatidyl-inositol 3-kinase delta
Inventor: SADHU CHANCHAL
IPC: C07D473/38
Filed: 2001-04-24
Abstract: Methods of inhibiting phosphatidylinositol 3-kinase delta isoform (PI3K delta)) activity, and methods of treating diseases, such as disorders of immunity and inflammation, in which PI3K delta plays a role in leukocyte function are disclosed. Preferably, the methods employ active agents that selectively inhibit PI3K delta, while not significantly inhibiting activity of other PI3K isoforms. Compounds are provided that inhibit PI3K delta activity, including compounds that selectively inhibit PI3K delta activity. Methods of using PI3K delta inhibitory compound s to inhibit cancer cell growth or proliferation are also provided. Accordingly, the invention provides methods of using PI3K delta inhibitory compounds to inhibit PI3K delta-mediated processes in vitro and in vivo.
Patent NZ-522613-A (NZ)
Title: Method and apparatus for sorting X-chromosome bearing and Y-chromosome bearing populations of spermatozoa and particle differentiation
Inventor: EVANS KENNETH M
IPC: C12N5/071
Filed: 2001-05-09
Abstract: An apparatus for differentiating asymmetric particles with particular application to providing high purity X-chromosome and Y-chromosome bearing populations of spermatozoa is described. The apparatus includes an irradiation source 12, such as a laser exciter, that produces a beam 31 that is focused to have a beam height of between one and three times the length of the asymmetric particles. A light emission material that emits light in response to the beam 31 is bound to the particles, and there is a detector 32 that responds to the emitted light. In the case of separating sperm cells fluorochrome is bound to the cell DNA. The selection of the beam height gives improved differentiation over previous separation devices where multiple sperm cell heads containing fluorochrome bound DNA can enter the irradiation beam pattern at the same time.
Patent NZ-530054-A (NZ)
Title: Dihydroimidazo [5,1-A]-beta-carboline derivatives, method for preparing same and use thereof as medicine
Inventor: FOURTILLAN JEAN-BERNARD
IPC: A61K31/437
Filed: 2002-05-16
Abstract: Disclosed are dihydroimidazo [5,1-a]-beta-carboline compounds of formula (I), wherein: R1, R2, R3 and R4 are independently H, halogen, alkyl, hydroxyl, alkoxy, trihalo-alkyl, trihalo-alkoxy, nitro, cyano, amino, alkylamino, dialkylamino, aryl, aryl-alkyl, carboxyl, alkylcarbonyloxy, acyl, aryloxy, or arylalkoxy, R5 is H, alkyl, aryl, and R6 and R7 are independently H, halo, alkyl, hydroxyl, alkoxy, trohalo-alkyl, trihalo-alkoxy, cyano, amino, alkylamino, dialkylamino, aryl, arylalkyl, carboxyl, alkylcarbonyloxy, acyl, aryloxy, or arylalkoxy. The compounds are used for the manufacture of medicaments for use as hypnotics.
Patent NZ-531150-A (NZ)
Title: Premeabilisation of cells
Inventor: RICKWOOD DAVID
IPC: C12N1/16
Filed: 2002-08-21
Abstract: A method for permeabilising a viable cell having a cell wall, such as a plant cell, comprising: (a) pressurizing a fluid or gel in contact with a surface of the cell; and (b) depressurizing the fluid or gel; to form at least one hole in a surface of the cell.
Patent NZ-533124-A (NZ)
Title: Production of viruses, viral isolates and vaccines
Inventor: MARZIO GIUSEPPE
IPC: A61K39/145
Filed: 2002-12-09
Abstract: A method for producing a virus particle, said method comprising the steps of: - contacting a cell with a virus particle in a culture medium under conditions conducive to infection of said cell by said virus particle ; and - culturing said cell under conditions conducive to propagation of said virus particle, wherein said cell over-expresses a nucleic acid encoding an alpha 2,6 sialyltransferase or a functional equivalent thereof.
Patent NZ-534822-A (NZ)
Title: Flax seed used to produce oil comprising a specified linolenic acid content
Inventor: KENASCHUK EDWARD O
IPC: A01H5/10
Filed: 2004-08-19
Abstract: Disclosed is a product comprising flax sees, flax meal or flax oil obtained from M5791 or progeny thereof wherein the flax component(s) have a linolenic acid content of substantially between 70 and 73.1%.
Patent NZ-536144-A (NZ)
Title: Method of deflavoring whey protein
Inventor: AKASHE AHMAD
IPC: A23L11/30
Filed: 2004-10-26
Abstract: A method for preparing deflavored whey protein material for use in dairy and non-dairy beverages, smoothies, health drinks, cheeses, cheese analogs, dairy and non-dairy yogurts, meat and meat analog products, cereals, baked products and snacks is described. The method is carried out by preparing an aqueous composition of a whey protein material containing soluble whey protein. The pH adjusted aqueous composition is passed through an ultrafiltration membrane wherein the flavor compounds pass through the membrane, thereby deflavoring the whey protein material and retaining the soluble whey proteins.
Patent NZ-537039-A (NZ)
Title: N-sulphonylaminoacetonitriles having pesticidal properties
Inventor: STEIGER ARTHUR
IPC: A01N41/06
Filed: 2003-06-18
Abstract: Disclosed herein are N-Sulphonylaminoacetonitrile compounds of the general formula (I) and enantiomers thereof wherein the variables are as defined in the specification. These active compounds are suitable for use in the control of parasites in particular, in warm-blooded animals.
Patent NZ-539076-A (NZ)
Title: Skin treatment compositions
Inventor: TAGG JOHN ROBERT
IPC: A61K35/74
Filed: 2005-03-29
Abstract: Disclosed are Micrococcus luteus containing compositions useful for controlling skin disorders, more particularly, to compositions intended for topical application to prevent or treat skin disorders in which bacteria are a causative component, for example, body odour, skin infections and acne. A new strain of Micrococcus luteus useful in these compositions is also disclosed.
Patent NZ-539446-A (NZ)
Title: Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists
Inventor: ANCLIFF RACHAEL
IPC: C07D239/28
Filed: 2003-10-14
Abstract: Disclosed are compounds of formula (I) wherein the substituents are described in the specification. Compounds of the type disclosed are H1 and or H3 antagonists or reverse antagonists useful in the treatment of neurological diseases and inflammatory diseases of the upper respiratory tract.
Patent NZ-539958-A (NZ)
Title: Modification of lignocellulosic materials with polymers
Inventor: FRANICH ROBERT ARTHUR
Filed: 2005-05-11
Abstract: A method of improving the strength, stiffness, dimensional stability, hardness, water repellency and fire retardancy of lignocellulosic materials by impregnating the lignocellulosic material with a composition consisting of a beta-linked oligosaccharide mixture and an amino resin, and by curing the composition within the impregnated lignocellulosic material by heat or heat and pressure.
Patent NZ-543768-A (NZ)
Title: Surrogate therapeutic endpoint for anti-CTLA-4 based immunotherapy of disease
Inventor: LOWY ISRAEL
IPC: G01N33/574
Filed: 2004-05-28
Abstract: Provided is the use of an anti-CTLA-4 antibody in the manufacture of a medicament for treating cancer in a patient in need of such treatment, wherein the medicament is formulated for administration according to a dosage regimen sufficient to induce a breakthrough event, wherein the dosage for that regimen has been determined by a procedure whereby the patient has been monitored for the occurrence of a breakthrough event after a measured amount of an anti-CTLA-4 antibody has been administered.
Patent NZ-545355-A (NZ)
Title: Use of polypeptides of the cupredoxin family in cancer therapy
Inventor: CHAKRABARTY AMANDA M
IPC: A61P35/00
Filed: 2004-08-10
Abstract: Provided is the use of a cupredoxin, selected from a pseudoazurin, a plastocyanin, a rusticyanin, or a fragment and/or truncation thereof, for the manufacture of a medicament for treating cancer by promoting cell death in a cancer cell. Further provided are specific amino acid sequences for similar uses.
Patent NZ-545631-A (NZ)
Title: Fexofenadine polymorphs and processes of preparing the same
Inventor: RAO DHARMARAJ RAMACHANDRA
IPC: A61P37/00
Filed: 2004-08-25
Abstract: The disclosure relates to anhydrous crystalline fexofenadine hydrochloride Form C, crystalline fexofenadine acetate monohydrate Form D, crystalline fexofenadine acetate dihydrate Form E and crystalline fexofenadine free base monohydrate Form F, processes of preparing the same, pharmaceutical compositions thereof, therapeutic uses thereof and methods of treatment therewith. Particularly disclosed is an anhydrous crystalline fexofenadine hydrochloride Form C having an X-ray diffraction pattern with characteristic peaks as shown in the Figure 1. The anhydrous crystalline fexofenadine hydrochloride Form C is suitable for antihistaminic treatment, wherein antihistaminic treatment denotes treatment of any of the following: bronchial spasms, sneezing, rhinorrhia, nasal congestion, lacrimation, redness, rash, urticaria and itch.
Patent NZ-548670-A (NZ)
Title: Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof
Inventor: SHIH CHARLES
IPC: A61K31/12
Filed: 2005-01-27
Abstract: Dislcosed is a method of inhibiting or reducing steroid-dependent gene activation comprising: a) providing a biological sample comprising a steroid receptor; b) administering a first compound to said biological sample, wherein said first compound induces degradation of said steroid receptor, and said first compound is selected from the group consisting of functional derivatives and functional analogues of curcumin; and c) administering a second compound to said biological sample, wherein said second compound inhibits said steroid receptor from activating a gene, and said second compound is selected from the group consisting of bicalutamide, hydroxyflutamide, docosahexaenoic acid (DHA), silibinin (SB), quercetin (QU), finesteride, dutasteride, vitamin E succinate (VES), and functional derivatives and functional analogues thereof; wherein said first compound and said second compound act at different steps within a gene activation pathway of said steroid receptor; further wherein steroid-dependent gene activation is reduced or inhibited greater than if said first compound or said second compound are administered alone. Further disclosed are pharmaceutical compositions and uses thereof.
Patent NZ-553828-A (NZ)
Title: Method of treating an inflammatory disease by double stranded ribonucleic acid by inhibiting TNF-alpha
Inventor: CUI KUNYUAN
IPC: A01N43/04
Filed: 2005-09-27
Abstract: Provided is a double stranded ribonucleic acid (dsRNA) molecule, comprising a sense strand and an antisense strand that form a double stranded region of about 19 base pairs to about 30 base pairs, wherein the antisense strand is complementary to a tumor necrosis factor-a (TNF-a) mRNA comprising a specified nucleic acid sequence. Further provided are corresponding pharmaceutical compositions and use of the dsRNAs in the manufacture of medicaments.
Patent NZ-553954-A (NZ)
Title: Intrauterine pressure catheter interface cable system
Inventor: ZAIKEN ELIOT J
IPC: G01R31/04
Filed: 2005-09-09
Abstract: An interface cable system for providing electrical interconnection between an intrauterine pressure catheter system and a monitoring system is disclosed. The interface cable system includes: a first connector (110) configured to provide electrical interconnection between the interface cable system and the intrauterine pressure catheter system; a second connector (104) configured to provide electrical interconnection between the interface cable system and the monitoring system; conductors (108) extending between the first connector and the second connector; a test plug (116) configured to be coupled to the first connector when the first connector is not coupled to the intrauterine pressure catheter system, in communication with the second connector for determining if the interface cable system is functioning properly; and an indicator (112) for providing an indication if it is determined that the interface cable system is functioning properly.
Patent NZ-560283-A (NZ)
Title: Rod-shaped light and light holder for marking a pylon
Inventor: WOBBEN ALOYS
IPC: F03D11/00
Filed: 2006-01-18
Abstract: A rod-shaped light 10 for a pylon comprises a substantially cylindrical rod-shaped holder at the first end of which lighting means and at the second end of which lighting means connections 15 are arranged. The rod-shaped light 10 is adapted to be fitted by means of the rod-shaped holder from the inside through a bore in the pylon wall 11 so that the lighting means radiate into the surrounding area of the pylon.
Patent NZ-567076-A (NZ)
Title: Apparatus for transporting products in crates or containers
Inventor: LEAHY JOHN CLIFTON
IPC: B62B3/08
Filed: 2006-09-05
Abstract: Disclosed is an apparatus which is selectively configurable as a pallet or a dolly. The apparatus includes a body having ground wheels, a support structure for one or more crates or containers, and at least one ground engageable member and latching means to latch the ground engageable member in a retracted position. The ground engageable member is fixed to the support structure, and is able to move vertically relative to the body between the retracted position, in which the apparatus is configured as a dolly freely moveable on a ground surface, and an extended position in which the ground engageable member engages an underlying ground surface to stabilise the apparatus against movement from that location. The assembly becomes a pallet support for the crates or containers. The ground engagable member has at least one transverse opening to receive a fork or forks of a lifting device. When lifted the ground engageable member rests on the fork(s), thereby facilitating transport of the apparatus and/or release and engagement of the latching means.
Patent NZ-575805-A (NZ)
Title: Polycyclic agents for the treatment of respiratory syncytial virus infections
Inventor: MITCHELL JEFFREY PETER
IPC: A61P31/14
Filed: 2007-09-26
Abstract: Disclosed are imidazole compounds represented by general formula (I). Examples of the compounds of general formula (I) include 10a-(4-chlorophenyl)-1-(2-pyridin-2-yl-acetyl)-2,3,10,10a-tetrahydro-1H-imidazol[1,2-b]isoquinolin-5-one and 9a-(4-chlorophenyl)-1-(furan-3-carbonyl)-8-oxy-2,3,9,9a-tetrahydro-1H-1,3a,8-triaza-cyclopenta[b]naphthalene-4-one. Also disclosed is the use of the compounds of formula (I) for treating respiratory syncytial virus (RSV).
Patent NZ-578515-A (NZ)
Title: Furling device with unfurling speed limitation device
Inventor: ZATTINI VLADIMIRO
IPC: B66D1/50
Filed: 2009-07-21
Abstract: A furling device (1) for furling flexible bodies (FB) wherein a frame (10) supports a drum (20) in an angularly rotatable manner about a fixed axis (22); an actuating unit (30) being mechanically connected to the drum (20) in order to rotate it axially so as to furl a flexible body (FB); a transmission unit (40) being arranged between the actuating unit and the drum (20), in order to transmit a torque to the drum (20) according to a given transmission ratio sufficient to control a furling action for furling the flexible body (FB); the transmission unit (40) comprising mechanical control means (50) suitable to cooperate with the actuating unit (30) in order to condition an unfurling of the flexible body (FB) from the drum (20).
Patent NZ-580226-A (NZ)
Title: Dimer compounds as inhibitors of iap
Inventor: FLYGARE JOHN A
IPC: C07D209/02
Filed: 2008-04-29
Abstract: Disclosed are inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds having the general formula U1 - M - U2 wherein M is a linking group covalently joining R2, R3, R4 or R5 of U1 to an R2, R3, R4 or R5 group of U2; U1 and U2 have the general formula (I) and G, X1, X2, R2, R3, R3', R4, R4' and R5, are as described in the description. Also disclosed is a method for introducing apoptosis in a cell of a non-human or in vitro using one of the dimer compounds and the use of a dimer compound in the manufacture of a medicament for treating a diseases or a condition. Further disclosed are compositions comprising a dimer compound.
Patent NZ-585947-A (NZ)
Title: Thermal and acid tolerant beta-xylosidases, genes encoding, related organisms, and methods
Inventor: THOMPSON DAVID N
IPC: D21C1/00
Filed: 2009-01-23
Abstract: Disclosed is an isolated or purified nucleic acid sequence comprising a nucleic acid sequence encoding a polypeptide having at least 90% sequence identity to the polypeptide of SEQ ID No.2. The polypeptide exhibits enzymatic activity at or below pH 5.5 and at a temperature at or above about 50 degrees Celsius. Also disclosed is the polypeptide having beta-xylosidase activity. The polypeptide can be used to at least partially degrade xylotriose or xylobiose.